GlaxoSmithKline PLC Director/PDMR Shareholding (1687T)
13 November 2019 - 2:51AM
UK Regulatory
TIDMGSK
RNS Number : 1687T
GlaxoSmithKline PLC
12 November 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms E Walmsley
=== ============================ =================================================
b) Position/status Chief Executive Officer
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP17.2659 7 (partnership shares)
=== ============================ ============== =============================
GBP17.2659 7 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP17.2659
=== ============================ =================================================
e) Date of the transaction 2019-11-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr R Connor
=== ============================ =================================================
b) Position/status President, Global Vaccines
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP17.2659 7 (partnership shares)
=== ============================ ============== =============================
GBP17.2659 7 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP17.2659
=== ============================ =================================================
e) Date of the transaction 2019-11-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms D Conrad
=== ============================ =================================================
b) Position/status SVP, Human Resources
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP17.2659 7 (partnership shares)
=== ============================ ============== =============================
GBP17.2659 7 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP17.2659
=== ============================ =================================================
e) Date of the transaction 2019-11-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr N Hirons
=== ============================ =================================================
b) Position/status SVP, Global Ethics and Compliance
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP17.2659 7 (partnership shares)
=== ============================ ============== =============================
GBP17.2659 7 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP17.2659
=== ============================ =================================================
e) Date of the transaction 2019-11-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms S Jackson
=== ============================ =================================================
b) Position/status SVP, Global Communications and CEO Office
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP17.2659 7 (partnership shares)
=== ============================ ============== =============================
GBP17.2659 7 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP17.2659
=== ============================ =================================================
e) Date of the transaction 2019-11-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Mr D Jackson
=== ============================ =====================================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
and CEO Office)
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GlaxoSmithKline plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP17.2659 7 (partnership shares)
=== ============================ ================ ===============================
GBP17.2659 7 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP17.2659
=== ============================ =====================================================
e) Date of the transaction 2019-11-11
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr D Redfern
=== ============================ =================================================
b) Position/status Chief Strategy Officer
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP17.2659 7 (partnership shares)
=== ============================ ============== =============================
GBP17.2659 7 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP17.2659
=== ============================ =================================================
e) Date of the transaction 2019-11-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr R Simard
=== ============================ =================================================
b) Position/status President, Pharmaceuticals Supply Chain
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP17.2659 7 (partnership shares)
=== ============================ ============== =============================
GBP17.2659 7 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP17.2659
=== ============================ =================================================
e) Date of the transaction 2019-11-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr P Thomson
=== ============================ =================================================
b) Position/status President, Global Affairs
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP17.2659 8 (partnership shares)
=== ============================ ============== =============================
GBP17.2659 8 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 16 Ordinary Shares
Price GBP17.2659
=== ============================ =================================================
e) Date of the transaction 2019-11-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms V Whyte
=== ============================ =================================================
b) Position/status Company Secretary
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan.
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP17.2659 7 (partnership shares)
=== ============================ ============== =============================
GBP17.2659 7 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 14 Ordinary Shares
Price GBP17.2659
=== ============================ =================================================
e) Date of the transaction 2019-11-11
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHELLFFKFFZFBK
(END) Dow Jones Newswires
November 12, 2019 10:51 ET (15:51 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024